Vaccine experts report positive results from phase 1 trial of personalized lymphoplasmacytic lymphoma vaccine
Single-cell RNA-seq analysis reveals vaccine-associated reduction in LPL B cells, but not plasma cell-like subpopulations in bone marrow. Credit: Nature ...